12/4
07:33 pm
twst
Twist Bioscience (TWST): Valuation Check After New Research-Grade Plasmid DNA Preps Boost Investor Interest [Yahoo! Finance]
Low
Report
Twist Bioscience (TWST): Valuation Check After New Research-Grade Plasmid DNA Preps Boost Investor Interest [Yahoo! Finance]
12/4
08:00 am
twst
Twist Bioscience Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics Research
Medium
Report
Twist Bioscience Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics Research
12/3
09:19 am
twst
Kuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law Firm
Medium
Report
Kuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law Firm
11/20
01:40 pm
twst
Twist Bioscience (NASDAQ:TWST) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Twist Bioscience (NASDAQ:TWST) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/19
01:42 pm
twst
Stephens Initiates Twist Bioscience (TWST) With Overweight Rating, Sets $41 PT [Yahoo! Finance]
Low
Report
Stephens Initiates Twist Bioscience (TWST) With Overweight Rating, Sets $41 PT [Yahoo! Finance]
11/18
04:35 pm
twst
Twist Bioscience Is Bent, Not Broken: Near-Term Strain, Long-Term Strength [Seeking Alpha]
Low
Report
Twist Bioscience Is Bent, Not Broken: Near-Term Strain, Long-Term Strength [Seeking Alpha]
11/17
10:23 am
twst
Twist Bioscience (NASDAQ:TWST) had its price target lowered by analysts at Barclays PLC from $40.00 to $37.00. They now have an "overweight" rating on the stock.
Low
Report
Twist Bioscience (NASDAQ:TWST) had its price target lowered by analysts at Barclays PLC from $40.00 to $37.00. They now have an "overweight" rating on the stock.
11/17
10:22 am
twst
Is Twist Bioscience Corporation (TWST) a Compelling Risk-Regarded Opportunity? [Yahoo! Finance]
Low
Report
Is Twist Bioscience Corporation (TWST) a Compelling Risk-Regarded Opportunity? [Yahoo! Finance]
11/17
09:30 am
twst
Can Twist Bioscience Drop More? [Forbes]
Low
Report
Can Twist Bioscience Drop More? [Forbes]
11/16
06:38 am
twst
Twist Bioscience (TWST) Is Down 11.2% After Record Revenue and MRD Express Launch Plans Announced [Yahoo! Finance]
Medium
Report
Twist Bioscience (TWST) Is Down 11.2% After Record Revenue and MRD Express Launch Plans Announced [Yahoo! Finance]
11/14
03:02 pm
twst
Twist Bioscience Corp (TWST) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ... [Yahoo! Finance]
Low
Report
Twist Bioscience Corp (TWST) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ... [Yahoo! Finance]
11/14
01:19 pm
twst
Twist Bioscience (NASDAQ:TWST) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Twist Bioscience (NASDAQ:TWST) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/14
12:04 pm
twst
Twist Bioscience Corporation (TWST) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
Twist Bioscience Corporation (TWST) Q4 2025 Earnings Call Transcript [Seeking Alpha]
11/14
08:17 am
twst
Twist Bioscience Announces Fiscal 2025 Fourth Quarter and Full Year Financial Results [Yahoo! Finance]
Low
Report
Twist Bioscience Announces Fiscal 2025 Fourth Quarter and Full Year Financial Results [Yahoo! Finance]
11/14
07:15 am
twst
Twist Bioscience Announces Fiscal 2025 Fourth Quarter and Full Year Financial Results
Medium
Report
Twist Bioscience Announces Fiscal 2025 Fourth Quarter and Full Year Financial Results
11/10
10:21 am
twst
Kuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law Firm
Low
Report
Kuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law Firm
11/5
07:32 am
twst
Twist Bioscience (NASDAQ:TWST) was upgraded by analysts at Stephens to a "strong-buy" rating.
Medium
Report
Twist Bioscience (NASDAQ:TWST) was upgraded by analysts at Stephens to a "strong-buy" rating.
11/4
08:00 am
twst
Twist Bioscience to Present at 7th Annual Wolfe Research Healthcare Conference
Low
Report
Twist Bioscience to Present at 7th Annual Wolfe Research Healthcare Conference
11/3
06:11 pm
twst
Twist Bioscience (NASDAQ:TWST) is now covered by analysts at Stephens. They set an "overweight" rating on the stock.
Medium
Report
Twist Bioscience (NASDAQ:TWST) is now covered by analysts at Stephens. They set an "overweight" rating on the stock.
11/3
08:00 am
twst
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Low
Report
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
10/24
06:20 am
twst
Halper Sadeh LLC Encourages Twist Bioscience Corporation Shareholders to Contact the Firm to Discuss Their Rights
Medium
Report
Halper Sadeh LLC Encourages Twist Bioscience Corporation Shareholders to Contact the Firm to Discuss Their Rights
10/23
08:00 am
twst
Twist Bioscience to Report Fiscal 2025 Fourth Quarter and Full Year Financial Results on Friday, November 14, 2025
Low
Report
Twist Bioscience to Report Fiscal 2025 Fourth Quarter and Full Year Financial Results on Friday, November 14, 2025
10/16
02:32 pm
twst
Kuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law Firm
Low
Report
Kuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law Firm
10/11
02:40 am
twst
Should Twist Bioscience's (TWST) Exclusive Access to New Sequencing Workflow Prompt Investor Attention? [Yahoo! Finance]
Low
Report
Should Twist Bioscience's (TWST) Exclusive Access to New Sequencing Workflow Prompt Investor Attention? [Yahoo! Finance]
10/10
08:11 pm
twst
A Fresh Look at Twist Bioscience's (TWST) Valuation After Its Recent 27% Share Price Surge [Yahoo! Finance]
Low
Report
A Fresh Look at Twist Bioscience's (TWST) Valuation After Its Recent 27% Share Price Surge [Yahoo! Finance]